Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis

被引：0
作者：
Helen Swede
Amna Sarwar
Anil Magge
Dejana Braithwaite
Linda S. Cook
David I. Gregorio
Beth A. Jones
Jessica R. Hoag
Lou Gonsalves
Andrew L. Salner
Kristen Zarfos
Biree Andemariam
Richard G. Stevens
Alicia G. Dugan
Mellisa Pensa
Jessica A. Brockmeyer
机构：
[1] University of Connecticut School of Medicine,Department of Community Medicine and Health Care
[2] University of California,Department of Epidemiology and Biostatistics
[3] San Francisco,Department of Epidemiology, Biostatistics and Preventive Medicine
[4] University of New Mexico,Connecticut Tumor Registry
[5] Yale School of Public Health,Helen & Harry Gray Cancer Center, Hartford Hospital
[6] Connecticut Department of Public Health,The Hospital of Central Connecticut
[7] Hartford HealthCare System,New England Sickle Cell Institute, Department of Medicine and Neag Cancer Center
[8] Hartford HealthCare System,Department of Occupational and Environmental Medicine
[9] University of Connecticut Health,undefined
[10] Yale School of Medicine,undefined
来源：
Cancer Causes & Control | 2016年 / 27卷
关键词：
Breast cancer; TNBC; Co-morbidity; Cancer survival disparity; Charlson Co-Morbidity Index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 636
页数：9
相关论文
共 177 条
[1]  
DeSantis C(2011)Breast cancer statistics, 2011 CA Cancer J Clin 61 409-418
[2]  
Siegel R(2011)Breast cancer racial disparities: unanswered questions Cancer Res 71 640-644
[3]  
Bandi P(2006)Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival Int J Radiat Oncol Biol Phys 65 1353-1360
[4]  
Jemal A(2010)Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004–2006 J Clin Oncol 28 4135-4141
[5]  
Ademuyiwa FO(2009)Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group J Natl Cancer Inst 101 984-992
[6]  
Edge SB(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29
[7]  
Erwin DO(2015)Cancer screening test use—United States, 2013 MMWR Morb Mortal Wkly Rep 64 464-468
[8]  
Orom H(2009)Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA Breast Cancer Res Treat 113 357-370
[9]  
Ambrosone CB(2011)Prevalence and prognostic role of triple-negative breast cancer by race: a surveillance study Clin Breast Cancer 11 332-341
[10]  
Underwood W(2009)Triple-negative/basal-like breast cancer: review Pathology 41 40-47
12345678910